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It is intuitive that immune cells in the gut may require microbiota-derived cues for their 
differentiation. The proximity between host and microbe in the intestine would seemingly 
necessitate co-adaptation. However, it has been challenging to determine the members and 
features of the gut microbiota that influence immune system development and function. The 
recent identification of immunomodulatory members of the commensal microbiota is providing 
insight into the dependence of select, intestinal immune cell subsets on specific microbial 
species. In this review, we focus on the gut microbiota’s influence on the development and 
function of mucosal T cells subsets, specifically intraepithelial lymphocytes and lamina propria 
CD4 T cells.
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delta (γδ) heterodimers. αβ IELs are primarily derived in the thymus 
and migrate into the intestine after development (Sheridan and 
Lefrancois, 2010). In contrast, γδ T cells are derived extrathymically 
and while they constitute a small fraction of T cells in peripheral 
lymph nodes and the spleen, 50% of IELs in mice express γδ. In 
humans, 15% of IELs in the small intestine (SI) and upward of 40% 
in the colon are γδ positive (Kagnoff, 1998). In response to bacteria 
or intestinal injury, γδ IELs produce proinflammatory cytokines 
and chemokines that recruit neutrophils, eosinophils, and T cells. 
γδ IELs also promote epithelial healing via production of keratino-
cyte growth factor, which stimulates epithelial cell proliferation and 
restoration of barrier function (Yang et al., 2004).
Despite the important role of γδ IELs in the intestine and their 
close proximity to luminal and mucosal microbes, relatively lit-
tle was known about their regulation by the gut microbiota until 
recently. Because of their small absolute numbers and propen-
sity for apoptosis when cultured ex vivo, γδ IELs have proven a 
challenging cell subset to study. The application of laser capture 
microdissection to the study of γδ IELs by the Hooper labora-
tory has provided a major advance for investigating this cell sub-
set (Ismail et al., 2009). While germ-free (GF) mice have equal 
numbers of γδ IELs compared with conventionally raised mice 
(Bandeira et al., 1990), data have emerged on the significant role 
of the gut microbiota on γδ IEL function. Ismail et al. (2009) have 
begun to unravel an elaborate and dynamic cross-talk between 
commensal bacteria and γδ IELs during mucosal injury that both 
promotes wound healing and prevents invasion by opportunistic 
pathogens. By comparing the transcriptional profiles of colonic 
γδ IELs isolated from conventional and GF mice both prior to 
and following injury with the mucosal disruptant, dextran sulfate 
sodium (DSS), Ismail et al. (2009) identified key effectors in the γδ 
IEL microbiota-dependent response to injury. While upregulation 
of lysozyme was a microbiota-independent function of IELs, the 
Overview
The mucosal immune system of the intestinal tract faces the 
 challenge of co-existing with a diverse and dynamic community 
of microbes while remaining poised to protect and defend against 
invasive pathogens. This microbiota is an active participant in host 
metabolism and also provides critical developmental cues for the 
immune system. Studies from animals models lacking all microbes, 
referred to as germ-free, have established that gut microbes are cru-
cial for the development, maturation, and function of the intestinal 
immune system and many aspects of systemic immunity. Mucosal 
T cells that reside within the epithelial cell layer and the lamina 
propria (LP) of the intestine are especially reliant on direct and indi-
rect microbial signals for their proper differentiation and function. 
Recently a few species, Bacteroides fragilis, Candidatus Arthromitus 
sp. segmented filamentous bacteria (SFB), and Clostridium spp. 
from Clostridium Clusters III, IV, and XIVa have been identified 
that drive both effector and/or regulatory mucosal T cell matura-
tion. In this review, we provide an introduction to mucosal T cell 
subsets, specifically intraepithelial lymphocytes and LP CD4 T cells, 
with a focus on the gut microbiota’s influence on their develop-
ment and function.
intraepithelial t lymphOcytes
Below the tight junctions that join the plasma membranes of epithe-
lial cells and residing above the basement membrane, are specialized 
subsets of gut T cells aptly named intraepithelial cell lymphocytes 
(IELs; Figure 1). IELs promote barrier repair, rapidly accumu-
late at sites of injury and infection, and defend against intestinal 
pathogens, such as Eimeria vermiformis (Roberts et al., 1996) and 
Salmonella spp. (Dalton et al., 2006). The majority of IELs express 
the CD8 glycoprotein, that binds MHC class I molecules (van Wijk 
and Cheroutre, 2009). IELs are categorized by the two chains that 
compose their T cell receptor: either alpha beta (αβ) or gamma 
Edited by:
Peter J. Turnbaugh, Harvard University, 
USA
Reviewed by:
Dennis L. Kasper, Harvard Medical 
School, USA
Daniel Peterson, University of 
Nebraska-Lincoln, USA
*Correspondence:
Wendy S. Garrett, Department of 
Immunology and Infectious Diseases, 
Harvard School of Public Health, 665 
Huntington Avenue, SPH 1, 9th Floor, 
Boston, MA 02115, USA.
e-mail: wgarrett@hsph.harvard.edu
www.frontiersin.org May 2011 | Volume 2 | Article 111 | 1
Review ARticle
published: 26 May 2011
doi: 10.3389/fmicb.2011.00111
ricidal activity, and B cell differentiation and antibody production. In 
general, T helper type 1 produce interferon-γ, TNF-α, and IL-12 and 
participate in host defense against intracellular pathogens; T helper 
type 2 produce IL-10, IL-13, IL-5, and IL-4 and defend against hel-
minths; and T helper 17 produce IL-17, IL-21, and IL-22 and afford 
protection against extracellular bacteria and parasites. Interactions 
between LP CD4 T cells and the gut microbiota, often with epithelial 
cells or dendritic cells functioning as the intermediaries, are critical 
for shaping the adaptive immune response in the intestine (Figure 2).
In healthy individuals all of these Th subsets are present in the 
LP and exist in a dynamic balance with regulatory CD4 T cells. 
Regulatory T cells also have many subsets especially in the gut. The 
environmental exposures (dietary components, resident intestinal 
microbes, transiently ingested microbes, and invasive pathogens) 
that the gut continuously encounters necessitate a nimble, diverse, 
and versatile functional potential of the adaptive T lymphoid com-
partment. There is also an increasing understanding of the func-
tional plasticity across CD4 subsets, especially for regulatory subsets 
and Th17 cells (Lee et al., 2009).
Both the gut and systemic immune system receive critical devel-
opmental cues from the intestinal microbiota. For example, GF 
rodents have marked abnormalities in mesenteric lymph nodes, 
peyer’s patches, and splenic architecture (Smith et al., 2007). In 
addition to impacting lymphoid structures and cell numbers, 
the microbiota influence lymphoid function under steady state 
conditions and in response to injury without any direct physical 
interaction. Surveys of the gut bacterial communities are revealing 
that there are alterations in the microbiota in both system and gut-
localized allergic and inflammatory disease (Cerf-Bensussan and 
Gaboriau-Routhiau, 2010). As T cells play critical effector roles in 
diseases like asthma, inflammatory bowel disease, type 1 diabetes, 
and multiple sclerosis, it is of great import to unravel the cause 
and effect relationships between the gut microbiota and LP T cell 
responses in allergic and autoimmune diseases.
induction of numerous chemokines (including KC and MIP2α), 
proinflammatory cytokines (e.g., IL-1β), and the bactericidal lectin 
RegIIIγ was microbiota-dependent. Importantly, colonization of 
GF mice with a specific pathogen-free (SPF) microbiota restored 
γδ IELs’ ability to promote wound healing. Furthermore, γδ IELs 
were also critical to protect against bacterial invasion immediately 
following intestinal injury as increased numbers of bacteria were 
detected in mesenteric lymph nodes in mice deficient in IELs 
(Ismail et al., 2009).
γδ IELs exhibit a multifaceted ability to promote intestinal home-
ostasis by responding directly to signals from the microbiota. The 
response of γδ IELs to gut microbes is only partially dependent on TLR 
signaling. Thus, it will be interesting to determine the other receptors, 
microbiota associated molecular patterns and specific bacterial species 
involved in orchestrating the IEL immune response to mucosal injury. 
Given that γδ IELs produce cytokines, such as IL-1β and TGFβ, that 
induce expansion of both antimicrobial and anti-inflammatory LP 
CD4 T cell subsets, respectively, it will also be interesting to determine 
how cross-talk between these two populations regulates intestinal 
homeostasis following injury and subsequent bacterial invasion.
lamina prOpria cD4 t lymphOcytes
Beneath the epithelial cell layer’s basement membrane is the LP 
region of the mucosa. The LP of the small and large intestine is 
home to 70–80% of the body’s immune cells (Furness et al., 1999). 
As opposed to the intraepithelial lymphoid compartment, popu-
lated with CD8 T cells, the LP is dominated by T cells expressing 
the CD4 glycoprotein, which binds MHC class II. While there are 
CD8 αβ and γδ LP populations, we focus on the many helper and 
regulatory CD4 T cells that reside in the LP and the evolving under-
standing of their relationship with gut microbiota.
Helper CD4 T cells (Th) represent a diverse collection of subsets 
with specific cytokines and chemokine profiles that result in activa-
tion and growth of cytotoxic T cells, promotion of myeloid cell bacte-
Figure 1 | A schema of the small intestinal mucosa. The crypt-villus axis 
of the small intestine is illustrated, as are its key immune subsets. Inset is an 
expanded view of the epithelium highlighting the γδ intraepithelial 
lymphocytes and several of the microbiota-dependent factors they produce in 
response to injury.
Figure 2 | immunomodulatory members of the gut microbiota that 
regulate lamina propria CD4 T cell subsets. Bacteroides fragilis, segmented 
filamentous bacteria, and Clostridium spp. are depicted along with the 
mechanisms by which they influence lamina propria CD4 T cell subsets.
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 commensal bacteria also affect the development of Th17 cells. Th17 
cells were identified as major mediators of pathology in several 
autoimmune and inflammatory disease models; however, Th17 
cells play an important role in host defense against extracellular 
bacteria and parasites (Korn et al., 2009). Th17 cells are found 
both in the LP of the SI and the colon and have an established role 
from studies in mouse models in defense against Shigella flexneri 
and Citrobacter rodentium (Ivanov et al., 2009; Sellge et al., 2010). 
Similar to findings with LP Th1 cells, Th17 cell numbers in the gut 
are also substantially reduced in GF mice, illustrating their depend-
ence on the gut microbiota. An astute observation about marked 
differences in LP Th17 cells between mice obtained from different 
commercial suppliers of laboratory animals garnered the atten-
tion of Dan Littman’s laboratory and led to their observation that 
the composition of the microbiota may be an important factor in 
inducing LP Th17 cells. In contrast with Th1 cells, colonization of 
GF mice with “any old” SPF microbiota was not enough to drive the 
development of LP Th17 cells, suggesting that particular bacterial 
species were required for Th17 cell development. The laboratories 
of Nadine Cerf-Bensussan and Dan Littman identified a role for 
SFB in driving LP Th17 cell development (Gaboriau-Routhiau 
et al., 2009; Ivanov et al., 2009). SFB are well known to mucosal 
immunologists interested in the role of microbiota and immune 
system development and have a well-established role in intestinal 
IgA and T cell responses (Talham et al., 1999). Colonization of GF 
mice with a SFB strain led to an increase in Th17 cell numbers, 
which restricted the growth and invasive capacity of Citrobacter 
rodentium providing a mechanism by which SFB can prevent inva-
sion by opportunistic bacteria (Ivanov et al., 2009).
Many questions still remain about how SFB drive gut Th17 cell 
development. Transcriptional profiling of mice colonized with SFB 
identified a substantial increase in the acute phase response protein 
serum amyloid A (SAA). SAA induced dendritic cells to produce 
the cytokines IL-6 and IL-23, both of which are important for Th17 
development (Korn et al., 2009). How SFBs mediate this effect is 
unclear, however, electron micrographs suggest that SFB are in close 
association with the epithelium of the terminal ileum (Klaasen 
et al., 1992). Although some intestinal dendritic cells can extend 
processes into the intestinal lumen (Chieppa et al., 2006), whether 
SFBs interact directly with dendritic cells or with epithelial cells 
as go-betweens remains unclear. A striking feature of SFBs, seen 
on some electron micrographs, are their terminal buds (tear-drop 
protuberances) that occur at attachment sites with the epithelium 
where the SFBs appear to perturb but not penetrate host epithe-
lial cell membranes (Klaasen et al., 1992; Ivanov et al., 2009). The 
whole genome sequence of the strain used in Ivanov et al. (2009) 
will likely prove quite informative in facilitating understanding of 
the host–microbiota interactions mediated by SFBs.
Bacteroides fragilis and SFBs are but a mere two out of the thou-
sands of species populating the mouse and human intestinal tracts. 
The identification of these bacteria raises many questions about 
microbiota-immune system co-evolution and adaptation. Have 
only a select number of gut microbes evolved immunomodula-
tory potential and can a few species modulate both helper and 
regulatory CD4 T cell behavior or have several bacterial species (or 
genera) evolved different effectors for different subsets? Who are 
the others and once identified, what are their immunomodulatory 
Gut micrObiOta anD th1–th2 cell equilibrium
T helper type 1 (Th1) and type 2 (Th2) balance has been a  useful 
paradigm facilitating understanding of both how the immune sys-
tem executes cellular and humoral immune responses and how 
imbalanced and over-exuberant responses underlie arthritis, type 
1 diabetes and multiple sclerosis in the case of Th1 immunity or 
asthma and allergic diseases in the case of Th2 immunity (Mosmann 
et al., 1986; Zhu et al., 2010). With the discovery of other T helper 
subsets, e.g., T helper 17 and T helper 9 and also regulatory subsets, 
the binary model of Th1 vs. Th2 is overly simplistic. However, 
early focus on these subsets during development and in GF mice 
was instrumental in understanding how the microbiota influence 
immune cell development. During the neonatal period; the imma-
ture fetal immune system is biased toward a Th2 phenotype, which 
if not corrected predisposes rodents and humans to infections, 
allergic and inflammatory diseases (Wilson, 1986; Holt, 1995). 
Prior to weaning, rats are skewed toward a Th2 biased phenotype 
in the spleen and mesenteric lymph node and lack basic Th1 cell 
mediated functions. These defects can be corrected by a lyophilized 
combination of bacteria including Staphylococcus, Streptococcus, 
and Klebsiella strains (Bowman and Holt, 2001). Recent studies in 
lymphopenic mice have provided mechanistic insight demonstrat-
ing that TLR ligands derived from the intestinal microbiota drive 
spontaneous T cell proliferation via innate cell production of IL-6 
(Feng et al., 2010). These data suggest that exposure to bacteria may 
be necessary to drive physiologic Th1 cell development. Subsequent 
studies have revealed that GF mice have reduced numbers of Th1 
cells in both systemic and mucosal compartments (Smith et al., 
2007). This reduction in basal Th1 immunity contributes to sus-
ceptibility to infection and morbidity with bacterial pathogens, 
including Shigella flexneri and Listeria monocytogenes (Round and 
Mazmanian, 2009). These early studies focused on Th1 and Th2 
cells established an important role for the gut microbiota in CD4 
T cell development systemically and within the gut.
While the human gut is home to trillions of bacteria cells 
representing a thousand species, B. fragilis was the first bacterial 
species identified that corrected the Th1 and Th2 cell imbalances 
observed in non-gut lymphoid tissues in GF mice. B. fragilis is a 
Gram-negative symbiont that inhabits the lower intestinal tract 
and colonizes an estimated 30–70% of humans (Sears and Pardoll, 
2011). Monocolonization of GF mice with B. fragilis induced overall 
CD4 T cell expansion and increased numbers of Th1 cells to levels 
similar to those of conventionally raised mice. Mechanistically, the 
effect of B. fragilis was entirely dependent on a zwitterionic capsular 
polysaccharide, polysaccharide A (PSA; Mazmanian et al., 2005). 
Exposure to PSA in vivo and in vitro was sufficient to induce Th1 
expansion and cytokine production and GF mice colonized with 
B. fragilis lacking PSA failed to correct their Th1/Th2 imbalance. 
As all humans and mice do not necessarily have B. fragilis in their 
gut, the intestinal microbiota undoubtedly harbors other symbiotic 
factors that facilitate systemic and intestinal Th1 cell development 
yet to be discovered.
Gut micrObiOta anD th17 cells
Early studies aimed at understanding how the gut microbiota affect 
LP CD4 T cell populations were mainly focused on the restora-
tion of Th1 responses; more recent work has shed light on how 
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of GF mice with either a single bacterial species or collection of 
bacterial strains can induce the differentiation of Tregs in the colon. 
In addition to its effects on systemic Th1 cells, B. fragilis and its 
immunomodulatory molecule, PSA, are capable of driving Treg 
differentiation (Round and Mazmanian, 2010). Monocolonization 
of GF mice with B. fragilis resulted in increased T cell expression 
of Foxp3+ and IL-10 in the colon, which was entirely depend-
ent on PSA (Round and Mazmanian, 2010). Furthermore, treat-
ment of T cells with PSA induced the development of functional 
Foxp3+ Tregs with suppressor activity that was likely dependent 
on IL-10. Importantly, PSA induced Foxp3+ Tregs were able to 
alleviate experimental colitis after onset of symptoms, indicating a 
potential use in therapeutic interventions (Mazmanian et al., 2008).
Recently Clostridium, a genus of Gram-positive bacteria that 
often are spore formers, have gained attention as potent inducers 
of gut Tregs. Investigations from the laboratory of Kenya Honda 
showed that while GF mice had markedly reduced colonic LP Foxp3+ 
Treg numbers, colonization with a collection of 46 Clostridium 
species restored Treg levels to that of conventionally raised mice 
(Atarashi et al., 2011a). There was a spatial correlation between 
colonic Treg distribution and the Clostridium strains along the 
intestine as both reach their highest density in the proximal colon 
(Atarashi et al., 2011a). Interestingly, the majority of Foxp3+IL-10+ 
Tregs induced by Clostridium were negative for Helios, which is a 
marker of natural (thymic-born) Tregs (Thornton et al., 2010). 
Therefore, the diminished Treg numbers observed in GF mice are 
likely inducible Tregs. Clostridium induced Tregs were functionally 
robust and afforded protection from intestinal inflammation in 
SPF mice challenged with the mucosal disruptant DSS (Atarashi 
et al., 2011a). Both Treg development and Treg-mediated protec-
tion from colitis were from the taxonomic Clostridium clusters IV 
and XIVa, which have been observed to have a reduced relative 
abundance in human inflammatory bowel disease patients com-
pared with healthy controls (Frank et al., 2007). Collectively, these 
studies suggest that the gut microbiota may contribute to a host’s 
resiliency from mucosa injury mediated by DSS and potentially that 
the absence of specific groups of bacteria may increase susceptibil-
ity to chronic inflammation. In particular, the experiments where 
Clostridium strains provided protection from DSS-mediated colitis 
raise hope that these strains hold potential as therapeutic agents.
Bacteroides fragilis and Clostridium spp.: separate paths to gut Treg 
expansion
Bacteroides fragilis and Clostridium spp. elicit Foxp3+IL-10+ induc-
ible Tregs through independent mechanisms. B. fragilis, through 
PSA, can act directly on CD4 T cells by inducing production of 
TGF-β2, which drives Treg differentiation (Round and Mazmanian, 
2010). In contrast, Clostridium species influence Treg differentia-
tion via epithelial cell-derived TGF-β1 (Atarashi et al., 2011a). 
There are also differences in the signaling pathways required for 
Treg development between these two bacteria. Tregs isolated from 
TLR2 deficient mice failed to expand in response to PSA and pro-
duced low levels of IL-10, consistent with a requirement for TLR2 
signaling (Round and Mazmanian, 2010). Interestingly, the effect 
of Clostridium was independent of several bacterial associated pat-
tern recognition receptors, and Treg induction occurred in mice 
deficient in MyD88, Rip2, and Card9-mediated signaling pathways 
molecules? Are immunomodulatory species equally effective for all 
individuals (mouse or human) and what host genes and signaling 
pathways are required for these bacterial-derived signals? Some 
of these questions have been answered for B. fragilis, which also 
appears to modulate immunity in both mice and humans, but much 
remains to be discovered.
lamina prOpria t reGulatOry cells
An important mechanism for maintaining intestinal homeostasis 
is the presence of CD4 regulatory T cells (Tregs) in the intestine. 
Regulatory CD4 T cells are important response modulators especially 
in the gut which is subject to: high luminal resident bacterial loads, 
incursions from pathogens, changing dietary components and also 
Th cells which require tuning of the intensity and duration of their 
inflammatory responses so that chronic inflammation does not ensue.
T regulatory cell subsets
There are two main subsets of CD4 Tregs present in the gut, natu-
rally occurring Tregs that develop in the thymus before trafficking 
to other sites in the body and inducible Tregs that develop in the 
periphery (Feuerer et al., 2009). The transcription factor Foxp3 
has been defined as a master regulator of Tregs and drives both 
differentiation and suppressive functions. However, there is also evi-
dence, especially in the intestine, of Tregs that do not express Foxp3. 
Tregs typically are able to exert their effects through dampening 
inflammatory responses by secreting anti-inflammatory cytokines, 
such as IL-10 (Maynard and Weaver, 2008). The importance of 
IL-10 as an inflammatory damper is evidenced by the spontaneous 
intestinal inflammation observed in IL-10 knock-out mice (Powrie 
and Leach, 1995). Interestingly, neither GF IL-10−/− nor SPF IL-10−/− 
mice that are not colonized with Helicobacter spp. (Kullberg et al., 
1998) develop spontaneous colitis. These observations have helped 
to establish the important role for IL-10 in the maintenance of 
homeostasis between the host and its gut microbiota.
Gut microbiota and T regulatory cells
Recent studies have identified a key role for the gut microbiota in the 
development of intestinal Tregs. The majority of Foxp3+ intestinal 
Tregs are found in the LP of the SI and colon (Atarashi et al., 2011b). 
Studies by the laboratory of Kenya Honda have revealed that in SPF 
mice the frequency of Foxp3+ Tregs in the SI and colon increased 
after weaning, whereas peripheral Treg populations remained stable 
(Atarashi et al., 2011a). Comparison of SPF mice to GF mice dem-
onstrated that while these mice have similar numbers of Tregs in the 
SI, GF mice have a significantly lower percentage of CD4+Foxp3+ 
Tregs in the colon. Furthermore, antibiotic treated mice also had 
significantly reduced numbers of Tregs in the colonic LP but not the 
SI. These findings imply that accumulation of Tregs in the colon and 
SI is differentially regulated and the colonic Treg differentiation is 
more heavily influenced by the microbiota (Atarashi et al., 2011b). 
Furthermore, these observations correlate with the increased num-
ber of luminal microbes in the colon vs. the SI and may suggest 
that inducible Tregs and the density and spatial organization of 
bacteria in the intestine may have coadapted.
Use of GF mice has been particularly helpful in deconstructing 
how single organisms and defined bacterial communities are able 
to instruct Treg responses. Recent work has shown that  colonization 
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imaging of dendritic cell extension 
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auxotrophic mutant  members (Hapfelmeier et al., 2010) offer new 
opportunities to deeply probe host–microbiota interactions and 
unravel co- adaptation in real time. Regarding the molecular cross-
talk between the immune system and microbes, the discovery of 
the toll-like receptor and nod-like receptor signaling pathways 
represents a ground-breaking contribution toward understand-
ing host– microbiota interaction. It is unlikely, however, that the 
dialog between the immune system and gut microbiota is limited 
to the current list of microbe associated molecular patterns. Gut 
microbes are efficient metabolic machines and their metabolites 
merit consideration as immune system cues. Both ATP and short 
chain fatty acids have emerged as microbiota-derived immune 
modulators – undoubtedly more bacterial immunomodulatory 
metabolites will be discovered (Maslowski and Mackay, 2011). 
Metagenomic surveys of the microbiota are providing vast 
amounts of information about the membership and function of 
the microbial world within the gut. Mucosal immunology is still 
discovering new T cell subsets and innate lymphoid cell lineages 
in the intestine. Thus, to paraphrase, the time is now and the 
place is the gut.
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(Atarashi et al., 2011a). Taken together, this indicates that genera 
from genetically disparate phyla have evolved distinct mechanisms 
to influence the development of T cell subsets necessary for host 
homeostasis. These non-redundant mechanisms afford alternative 
opportunities for inducible Treg differentiation should genera be 
temporarily (or permanently) lost secondary to a course of anti-
biotics or an inflammatory process.
cOnclusiOns anD Future DirectiOns
It is intuitive that immune cells in the gut may depend on micro-
biota-derived cues for their development. The proximity between 
host and microbe in the intestine would seemingly necessitate 
co-adaptation. However, it has been challenging to determine 
the members and features of the gut microbiota that influence 
immune system development and function. Animal models, par-
ticularly those wherein the microbiota can be manipulated, are 
revealing how the gut microbiota profoundly influence the devel-
opment of host intestinal immune responses. The use of GF mice, 
a tool that is over 50 years old (Reyniers, 1957), is providing fresh 
insight into the species-selectivity of gut T cell subset develop-
ment. Much still remains to be understood about interactions of 
such select species (e.g., SFB and Clostridium spp.) with other gut 
microbial community members and the bacterial-derived signals 
sensed by the host. More nuanced ways to manipulate complex 
microbial communities will be essential to unravel host–immune 
interactions. Transposon-based mutagenesis strategies selec-
tively targeting single organisms within a complex community 
(Goodman et al., 2009) or dynamic communities designed with 
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